ABSTRACTObjectiveTo describe the most common sexual problems and changes experienced by male urological cancer survivors, focusing on evidence-based practices for assessment and intervention.Materials and MethodsWe search the PubMed, Embase, and SciELO databases between 1994 and 2022, using the following key words: “urological cancer”, “urological malignances”, “genitourinary cancer”, “male sexual health”, and “male sexual dysfunction”.ResultsThis narrative review provides an overview of the current literature involving the impact of diagnosis and treatment of urological cancers on male sexual function. Male “genital” or “reproductive” tumors, such as prostate, penile, and testicular tumors, clearly appear to affect sexual function. However, tumors that do not involve genital parts of the body, such as the bladder and kidney, can also affect male sexual function.ConclusionMale sexual dysfunction is very common after urologic cancer diagnosis and treatment. Changes in body image and anatomical damage can be associated with impaired masculinity and sexual function, especially after prostate, penile or testicular cancer treatment. Moreover, anxiety, depression, and fear of recurrence have an impact on quality of life and sexual function regardless of the cancer location. Therefore, patients need be counseled about the likely changes in sexual function before treatment of any urological cancer.